Related Experiment Video
Updated: Jun 5, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function
Yosuke Kanno1, Akira Ishisaki, Eri Kawashita
1Department of Clinical Pathological Biochemistry, Faculty of Pharmaceutical Science, Doshisha Women's Collage of Liberal Arts, 97-1 Kodo Kyo-tanabe, Kyoto 610-0395, Japan. ykanno@dwc.doshisha.ac.jp
Plasminogen absence increases osteoclast precursors and bone loss by suppressing osteoprotegerin. Restoring plasmin levels normalizes bone metabolism, suggesting new therapies for fibrinolytic bone diseases.
Area of Science:
- Biochemistry
- Bone Biology
- Fibrinolysis
Background:
- Plasminogen (Plg) and plasmin are implicated as key regulators of bone metabolism.
- Their precise role in osteoblast (OB) and osteoclast (OC) function requires further elucidation.
Purpose of the Study:
- To investigate the impact of plasminogen absence on osteoblast and osteoclast function.
- To explore the therapeutic potential of plasmin in modulating bone metabolism.
Main Methods:
- Comparative analysis of bone marrow-derived cells from Plg(-/-) and wild-type (WT) mice.
- Assessment of osteoclastogenesis in co-culture systems involving OBs and RAW264.7 cells.
- Evaluation of osteoprotegerin expression in OBs with and without exogenous plasmin treatment.
Main Results:
- Plg(-/-) mice exhibited a larger pre-osteoclast population and suppressed osteoprotegerin expression in osteoblasts.
- Exogenous plasmin induced osteoprotegerin expression in Plg(-/-) osteoblasts.
- Osteoclastogenesis was accelerated in co-cultures with Plg(-/-) osteoblasts, an effect reversed by exogenous plasmin.
- Plg(-/-) mice showed decreased bone mineral density.
Conclusions:
- Plasminogen plays a crucial role in regulating osteoblast and osteoclast function.
- Disruption of the fibrinolytic system, specifically plasminogen deficiency, leads to impaired bone metabolism and reduced bone mineral density.
- Targeting the plasminogen/plasmin system offers potential therapeutic strategies for bone diseases.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Matrix Metalloproteases in Degradation of ECM
A...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
